GSK hires at Sligo facility; Apotex recalls nearly 92,000 bottles of Losartan;

> GlaxoSmithKline intends ($GSK) to add 50 employees to its consumer plant in Sligo, Ireland. Report

> U.K.-based CMO Quantum Pharma has expanded its manufacturing capabilities with the £9.34 million ($14.57 million) acquisition of NuPharm Group. Report

> Canadian drugmaker Apotex is recalling about 92,000 bottles of the hypertension drug Losartan saying it may not meet the limit for blend uniformity specification. Notice

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)